Please login to the form below

Not currently logged in
Email:
Password:

Emma Walmsley

This page shows the latest Emma Walmsley news and features for those working in and with pharma, biotech and healthcare.

GSK beats expectations thanks to strong vaccine sales in Q2

GSK beats expectations thanks to strong vaccine sales in Q2

range for 2021, and meaningful performance improvement in 2022,” said Emma Walmsley, chief executive officer of GSK. ... In response, GSK’s board said that it ‘strongly believes’ that Walmsley is the ‘right leader’ for the new biopharma

Latest news

More from news
Approximately 2 fully matching, plus 56 partially matching documents found.

Latest Intelligence

  • Women Leaders in UK Healthcare: Liz Henderson Women Leaders in UK Healthcare: Liz Henderson

    It’s also great to see outside Merck that women are also progressing in other companies too – like Emma Walmsley at GSK – which gives women the inspiration that they too can

  • 25 Women Leaders in UK Healthcare 25 Women Leaders in UK Healthcare

    10. THEODORA HAROLD  . Biotech leader. While big pharma is making some significant strides in having women as their top leaders (most notably GSK’s CEO Emma Walmsley), the biotech sector, particularly

  • Diversity and inclusion in the pharma industry Diversity and inclusion in the pharma industry

    If, as GlaxoSmithKline CEO Emma Walmsley said, talking about diversity to Business Insider UK, ‘‘You cannot be a modern employer in an industry that should be future facing and modernising arguably

  • 30 Women Leaders in UK Healthcare (part 3) 30 Women Leaders in UK Healthcare (part 3)

    29. Emma Walmsley, GSK CEO. Emma Walmsley is the first-ever woman leader of a big pharma company, having taken on the CEO role at GlaxoSmithKline in April 2017. ... Since then, Walmsley has very definitely put her own stamp on the firm, making major

  • Pharma deals continue to slide Pharma deals continue to slide

    Emma Walmsley, CEO of GSK, said: “We will use cash for business development purposes, with M&A obviously dependent on the right kind of return profile.”.

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

Health literacy in the time of COVID-19
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...
Rare thoughts & outcomes - navigating pathways to better outcomes in rare
...
How to pick the perfect training program for your healthcare professionals
You know your team needs training. But not all training providers and programs are created equal. Last week, we shared the benefits of working with specialist learning and development (L&D)...